Ginkgo Bioworks Announces Participation in Cowen's 43rd Annual Health Care Conference

2023-03-02

BOSTON, March 2, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced today that Co-Founder and CEO Jason Kelly is scheduled to participate in Cowen's 43rd Annual Health Care Conference, including:

Fireside chat on Monday, March 6, 2023, at 9:10 a.m. ET

SynBio & AI Driven Drug Discovery panel on Monday, March 6, 2023, at 4:40 p.m. ET

Further details, webcast links, and a replay of the fireside chat and panel, if available, will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events/.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

[email protected]

MEDIA CONTACT:

[email protected]

SOURCE Ginkgo Bioworks

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构